Table 1.
Expression of p27Kip1, MIB1, and p53 in 66 NHLs
| NHL | Cases | p27Kip1+ cells (range) | MIB1+ cells (range) | p53+ no. of cases |
|---|---|---|---|---|
| Follicular lymphoma | 21 | 65% (0–98) | 41% (10–98) | 6* |
| Diffuse large B-cell lymphoma | 20† | 23% (0–98) | 74% (42–99) | 5 |
| Group 1 | 10 | 0 | 74% (42–99) | 3 |
| Group 2 | 6 | 28% (17–43) | 64% (42–80) | 1 |
| Group 3 | 4 | 80% (60–98) | 85% (66–98) | 1 |
| B-cell chronic lymphocytic leukemia | 16 | 85% (71–100) | 17% (6–30) | 0 |
| Marginal zone B-cell lymphoma | 8 | 90% (74–100) | 12% (1–38) | ND |
| Splenic marginal zone lymphoma | 1 | 66% | 40% | ND |
*p53-positive cases were all grade III with diffuse areas.
†Total group.